Positive trial results for needle free transdermal glucose monitoring device for critical care patients

Published date : 06 August 2012
Article date : 06 August 2012

This was the second of 2 clinical trials for the Echo Therapeutics' Symphony system.  
The study was undertaken at Thomas Jefferson University Hospital. It enrolled 15 adult patients in critical care settings undergoing major general surgery and cardiothoracic surgery. Blood samples were taken from arterial line catheters at 30-minute intervals and measured on a YSI 2300 STAT Plus Glucose Analyzer. 1,200 Symphony tCGM glucose readings were taken. The device’s error rate was 9 percent and a Continuous Glucose-Error Grid analysis showed that 98.9 percent of the readings were clinically accurate, according to the statement.
Echo Therapeutics plans to meet with the European regulatory authorities and the U.S. Food and Drug Administration and will seek CE Mark approval in Europe before completing a pivotal trial and filing for FDA approval.
Read more here
Back to Listings

WhichMedicalDevice is a FREE resource created by clinicians for clinicians.

Registration is free and gives you unlimited access to all of the content and features of this website.

Find out more...

Please sign in to view this content...

I have forgotten my password
Not a Member?

Registration is free and gives you unlimited access to all of the content and features of Which Medical Device. Find out more...

Why Register

Which Medical Device is a community of clinicians sharing knowledge and experience of the devices and procedures we use on a daily basis. We ask that our members register with us so that we can maintain the unbiased and independent nature of our content. Registration is quick and free.

We do not make your details available to any third parties nor do we send unsolicited emails to our members. You can read our Privacy Policy here.